What You Should Know:
Biostage, Inc., a cell-therapy biotechnology company with successful first-in-human experience in treating esophageal cancer and FDA approval to commence a clinical trial of the Biostage Esophageal Implant raises $6M from new and existing investors in a private placement of its shares of common stock.The funds will be used to accelerate the clinical development of Biostage’s lead product candidate, the Biostage Esophageal Implant, or BEI. The FDA has approved a
Read More
Cancer | Digital Health Impact on Cancer Care | Policy, News, Analysis, Insights - HIT Consultant
ChatGPT Has Potential to Help Cirrhosis, Liver Cancer Patients, Cedars Sinai Study Reveals
What You Should Know:
A new study by Cedars-Sinai investigators describes how ChatGPT, an artificial intelligence (AI) chatbot, may help improve health outcomes for patients with cirrhosis and liver cancer by providing easy-to-understand information about basic knowledge, lifestyle and treatments for these conditions.The findings, published in the peer-reviewed journal Clinical and Molecular Hepatology, highlight the AI system’s potential to play a role in clinical practice.
Helping
Read More
Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response
What You Should Know:
Genialis, a computational precision medicine company unraveling complex biology to find new ways to address disease, today announced it raised more than $13 million in Series A financing to transform the way diseases are diagnosed and treatment decisions are made.Taiwania Capital and Debiopharm Innovation Fund co-led the round, with participation from previous investors First Star Ventures, Redalpine Venture Partners, and Pikas. Other new investors include P5 Health
Read More
5 AI-Driven Healthcare Trends and Solutions in 2023
Enterprise-level healthcare is a massive business sector with seemingly infinite moving parts. With patients’ lives at stake, liability is huge, leaving little room for error. Yet human error is common in healthcare, and minor mistakes can cost millions in legal fees and lawsuits, not to mention risks to patient health. Healthcare enterprises are quickly embracing artificial intelligence solutions to mitigate loss, streamline operations, improve efficiency, and enhance customer
Read More
17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity
Clinician shortage has reached a new level of urgency as we face rising demand and healthcare costs, according to a recent Accenture report. Healthcare workers are increasingly burned out and leaving the industry altogether in droves. Those who remain to do the work are overburdened. We ask seventeen healthcare IT executives for their insights on how health IT solutions could potentially help address clinician burnout, clinician staffing shortages, and deal with capacity.
Staffing levels
Read More
Vivante Expands Virtual GI Care with AI-Driven Care Plans
What You Should Know:
- Vivante Health, a provider of digital digestive health solutions for employers and health plans, is expanding its GIThrive platform with enhanced technology that optimizes triage, telemedicine appointments with physicians in every state when needed, and more
- GIThrive’s virtual care model will now be powered by enhanced technology that facilitates triage, including access to all existing GIThrive features plus GI-related test ordering,
Read More
Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care
What You Should Know:
- A recent study published in JAMA found that conventional genomic tests commonly used for breast cancer tumors can be less accurate for Black women. This news comes at a time when Black women with breast cancer are experiencing mortality rates that are 41% higher than white women.
- Dr. Nathalie Johnson, MD FACS and President of The American Society of Breast Cancer Surgeons is among numerous doctors who advocate for Agendia and its tests which look beyond race,
Read More
Artera Launches with $90M for Multimodal AI, Predictive Cancer Tests
What You Should Know:
- Artera, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, launches publicly today with $90M in funding.
- The investment comes from a syndicate of prominent tech and healthcare investors, comprised of seven institutions (Coatue, Johnson & Johnson, Koch Disruptive Technologies, Walden Catalyst Ventures, TIME Ventures, Breyer Capital, The Factory) and 11 angel investors (Marc Benioff, Jim Breyer, Lip-Bu Tan, Chris
Read More
Accelerating Clinical Trials Through AI-Enabled Precision Oncology
The American Cancer Society’s Cancer Statistics 2023 report highlighted a few major accomplishments within oncology, such as decreased cancer mortality rates and increased trial diversity. However, there is still much work to be done. Especially with the multiple types of new and ongoing challenges clinicians and staff members are facing - such as high turnover rates, decreased budgets and increased feelings of burnout - taking the necessary steps to enhance clinical trial procedures is crucial
Read More
Accenture: Data Collaboratives Hold Great Promise for Accelerated Healthcare Progress and Precision Medicine
What You Should Know:
- Accenture published Fast-Forwarding Healthcare through Data Collaboratives Report to discover how best health ecosystem players access data to fast-forward healthcare.
- Data generated by technical and scientific advances, like connected health devices, consumer health and medical-grade digital apps, individual multi-omics profiling data and the move to cloud storage, holds great promise for accelerated healthcare progress and precision medicine, and data
Read More
